Supporting generational innovation

EXECUTION APPROACH

Strategic Grant Making: A disciplined, mission-driven approach to philanthropy that transforms the funder-grantee relationship from transactional to transformational. We deploy non-dilutive capital with surgical precision at the inflection point where a breakthrough either reaches communities or disappears.

• Fund Breakthrough Generational Health Innovations to accelerate measurable science and technology protecting the biology and environment for the next generations.

• Activate Strategic Partnerships to deploy innovations at scale, and drive measurable adoption of breakthrough technologies in target communities.

• Implement and Standardize effective philanthropic funding models in collaboration with strategic partners

VENTURE PHILANTHROPY & INNOVATION PARTNERSHIP, ACCELERATING SCALABLE GENERATIONAL HEALTH SOLUTIONS

• Identify and fund scientific innovations leading to scalable technology solutions that face long timelines and the least access to early capital

• Implement global, scalable technology programs for Generational Health addressing unmet needs across four or more generations

• Fuel innovation adoption with partners including UNFPA, WHO, the Catalytic Impact Foundation, Blue Zones, and others for strategy development, and deployment at the community level

Partner with mission-aligned businesses and media platforms to scale awareness and adoption of multigenerational health solutions across global communities

GENERATIONAL HEALTH FUNDING CONSORTIUM,

BROADENING THE APERTURE ON GLOBAL HEALTH INNOVATION

• Open the aperture on health for women, families, and communities with philanthropic funding in the intersections that broaden the thesis across women's health, nutrition, brain health, longevity, and environmental exposures

• Partner with philanthropists, family offices, DAFs, corporations, and foundations to pool and deploy capital toward high-impact gaps that traditional funding models chronically overlook

Catalyze breakthrough science with long-horizon impact — directing strategic, non-dilutive funding towardedge-case technologies such as genetic therapies, new diagnostics, and treatments for conditions that protect multigenerational health outcomes.